Healixa, Inc. (OTC Pink: EMOR), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, announced the completion of the national application filing phase, in accordance with the Patent Cooperation Treaty (“PCT”), for patent coverage in 132 countries for the Company’s Global AquaDuct™ Atmospheric Water Harvesting® (AWH®) product. “As our team prepares for the upcoming commercial launch of our Global AquaDuct™ water harvesting device, we are ensuring we have robust patent protections in place, and with the final phase of the PCT process now complete, we are one step closer to securing patent coverage in 132 countries globally,” commented Ian Parker, Chairman and CEO of Healixa.

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that its recently launched collaboration with Clearmind Medicine Inc. (“Clearmind”) (CSE: CMND), (OTC: CMNDF), (FSE: CWY0), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, resulted in the filing of a provisional patent application related to treating cocaine addiction. The patent application refers to the proprietary combination of SciSparc's CannAmide™ with Clearmind's MEAI, for treating cocaine addiction.

TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology company committed to defeating cancer using RNA therapeutics, announced that it was awarded the second tranche of funding from a Fast-Track Small Business Innovation Research (SBIR) grant from the National Cancer Institute of the NIH (Award Number R44CA257093). The SBIR award, totaling $2.3 million, supports the continued clinical evaluation of TTX-MC138, TransCode’s lead therapeutic candidate for the treatment of advanced solid tumors. The Company achieved the first milestone related to the SBIR grant during the first quarter of 2022 -triggering a payment of $1.1 million as the second tranche of the award.

Save Foods (NASDAQ: SVFD) (FSE:80W), an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety, provided a letter to stockholders to advise them of the EU’s Farm to Fork and Biodiversity strategies, in which the EU has set a goal of reducing pesticide use by 50% by 2030. CEO Dan Sztybel’s letter stated that this goal presents an immediate market opportunity for Save Foods in Europe. In addition, Sztybel, revealed plans to rapidly expanded its presence in key markets that export to Europe, including Turkey, South Africa, Mexico, Peru, and Columbia.